The paradoxical effects of vitamin D on type 1 mediated immunity

Molecular Aspects of Medicine

Volumn 29, Issue 6, 2008, Pages 369-375

  Cantorna, Margherita T ^a   Yu, Sanhong ^a   Bruce, Danny ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Immune regulation; Infectious immunity; Inflammatory bowel disease; Vitamin D

Indexed keywords

CALCITRIOL; VITAMIN D;

ANTIBACTERIAL ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANDIDA ALBICANS; CANDIDIASIS; ENTERITIS; HUMAN; HYGIENE; IMMUNE RESPONSE; IMMUNE SYSTEM; KIDNEY; LEISHMANIA MAJOR; LISTERIA; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH2 CELL; TH3 CELL; TUBERCULOSIS;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; KIDNEY; STEROID HYDROXYLASES; TH1 CELLS; VITAMIN D;

ANIMALIA;

EID: 56149107836     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2008.04.004     Document Type: Review

References (59)

1. Abreu M.T., Kantorovich V., Vasiliauskas E.A., Gruntmanis U., Matuk R., Daigle K., Chen S., Zehnder D., Lin Y.C., Yang H., Hewison M., and Adams J.S. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53 8 (2004) 1129-1136
2. Adorini L., Penna G., Giarratana N., and Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell Biochem. 88 2 (2003) 227-233
3. Akbari O., Stock P., DeKruyff R.H., and Umetsu D.T. Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol. 15 6 (2003) 627-633
4. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., and Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9 5 (2003) 582-588
5. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., and O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195 5 (2002) 603-616
6. Bhalla A.K., Amento E.P., Clemens T.L., Holick M.F., and Krane S.M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57 6 (1983) 1308-1310
7. Cantorna M.T. Vitamin D and autoimmunity: Is vitamin D status an environmental factor affecting autoimmune disease prevalence?. Proc. Soc. Exp. Biol. Med. 223 3 (2000) 230-233
8. Cantorna M.T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 92 1 (2006) 60-64
9. Cantorna M.T., and Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229 11 (2004) 1136-1142
10. Cantorna M.T., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93 15 (1996) 7861-7864
11. Cantorna M.T., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 128 1 (1998) 68-72
12. Cantorna M.T., Hullett D.A., Redaelli C., Brandt C.R., Humpal-Winter J., Sollinger H.W., and Deluca H.F. 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 66 7 (1998) 828-831
13. Cantorna M.T., Munsick C., Bemiss C., and Mahon B.D. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130 11 (2000) 2648-2652
14. Christen U., and von Herrath M.G. Infections and autoimmunity - good or bad?. J. Immunol. 174 12 (2005) 7481-7486
15. Clemens T.L., Adams J.S., Nolan J.M., and Holick M.F. Measurement of circulating vitamin D in man. Clin. Chim. Acta 121 3 (1982) 301-308
16. Clohisy D.R., Bar-Shavit Z., Chappel J.C., and Teitelbaum S.L. 1,25-Dihydroxyvitamin D3 modulates bone marrow macrophage precursor proliferation and differentiation. Up-regulation of the mannose receptor. J. Biol. Chem. 262 33 (1987) 15922-15929
17. Conron M., Young C., and Beynon H.L. Calcium metabolism in sarcoidosis and its clinical implications. Rheumatology (Oxford) 39 7 (2000) 707-713
18. DeLuca H.F. Vitamin D. Nutr. Today 28 (1993) 6-11
19. Ehrchen J., Helming L., Varga G., Pasche B., Loser K., Gunzer M., Sunderkotter C., Sorg C., Roth J., and Lengeling A. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 21 12 (2007) 3208-3218
20. Falk S., Kratzsch J., Paschke R., and Koch C.A. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Med. Sci. Monit. 13 11 (2007) CS133-CS136
21. Froicu M., and Cantorna M.T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8 (2007) 5
22. Froicu M., Weaver V., Wynn T.A., McDowell M.A., Welsh J.E., and Cantorna M.T. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17 12 (2003) 2386-2392
23. Froicu M., Zhu Y., and Cantorna M.T. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 117 3 (2006) 310-318
24. Gibney K.B., MacGregor L., Leder K., Torresi J., Marshall C., Ebeling P.R., and Biggs B.A. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin. Infect Dis. 46 3 (2008) 443-446
25. Glendenning P., Taranto M., Noble J.M., Musk A.A., Hammond C., Goldswain P.R., Fraser W.D., and Vasikaran S.D. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann. Clin. Biochem. 43 Pt 1 (2006) 23-30
26. Griffin M.D., and Kumar R. Effects of 1alpha,25(OH)2D3 and its analogs on dendritic cell function. J. Cell Biochem. 88 2 (2003) 323-326
27. Helming L., Bose J., Ehrchen J., Schiebe S., Frahm T., Geffers R., Probst-Kepper M., Balling R., and Lengeling A. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106 13 (2005) 4351-4358
28. Hewison M., Burke F., Evans K.N., Lammas D.A., Sansom D.M., Liu P., Modlin R.L., and Adams J.S. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid. Biochem. Mol. Biol. 103 3-5 (2007) 316-321
29. Hougardy J.M., Place S., Hildebrand M., Drowart A., Debrie A.S., Locht C., and Mascart F. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am. J. Resp. Crit. Care Med. 176 4 (2007) 409-416
30. Iwakura Y., and Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116 5 (2006) 1218-1222
31. Kaposzta R., Tree P., Marodi L., and Gordon S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun. 66 4 (1998) 1708-1717
32. Khan W.I., Blennerhasset P.A., Varghese A.K., Chowdhury S.K., Omsted P., Deng Y., and Collins S.M. Intestinal nematode infection ameliorates experimental colitis in mice. Infect. Immun. 70 11 (2002) 5931-5937
33. Koeffler H.P., Amatruda T., Ikekawa N., Kobayashi Y., and DeLuca H.F. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res. 44 12 Pt 1 (1984) 5624-5628
34. Koloski N.A., Bret L., and Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J. Gastroenterol. 14 2 (2008) 165-173
35. Lemire J.M., and Archer D.C. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87 3 (1991) 1103-1107
36. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., and Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 5768 (2006) 1770-1773
37. Mahon B.D., Wittke A., Weaver V., and Cantorna M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell Biochem. 89 5 (2003) 922-932
38. Marshall T.G. Vitamin D discovery outpaces FDA decision making. Bioessays 30 2 (2008) 173-182
39. Marshall T.G., and Marshall F.E. Sarcoidosis succumbs to antibiotics - implications for autoimmune disease. Autoimmun. Rev. 3 4 (2004) 295-300
40. Mathieu C., van Etten E., Decallonne B., Guilietti A., Gysemans C., Bouillon R., and Overbergh L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J. Steroid. Biochem. Mol. Biol. 89-90 1-5 (2004) 449-452
41. Maul J., Loddenkemper C., Mundt P., Berg E., Giese T., Stallmach A., Zeitz M., and Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128 7 (2005) 1868-1878
42. Neissner M., and Volk B.A. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reverse transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101 (1995) 428-435
43. Podolsky D.K. Inflammatory bowel disease (1). N. Engl. J. Med. 325 13 (1991) 928-937
44. Podolsky D.K. Inflammatory bowel disease (2). N. Engl. J. Med. 325 14 (1991) 1008-1016
45. Provvedini D.M., Tsoukas C.D., Deftos L.J., and Manolagas S.C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221 4616 (1983) 1181-1183
46. Rolfe V.E., Fortun P.J., Hawkey C.J., and Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 4 (2006) CD004826
47. Scott-Browne J.P., Shafiani S., Tucker-Heard G., Ishida-Tsubota K., Fontenot J.D., Rudensky A.Y., Bevan M.J., and Urdahl K.B. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204 9 (2007) 2159-2169
48. Staeva-Vieira T.P., and Freedman L.P. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol. 168 3 (2002) 1181-1189
49. Strober W., Fuss I., and Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117 3 (2007) 514-521
50. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
51. Tuohy K.A., and Steinman T.I. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn's disease. Am. J. Kidney Dis. 45 1 (2005) e3-e6
52. Veldman C.M., Cantorna M.T., and DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 374 2 (2000) 334-338
53. Vidyarani M., Selvaraj P., Jawahar M.S., and Narayanan P.R. 1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis. Cytokine 40 2 (2007) 128-134
54. Volpicelli G., Mussa A., and Frascisco M. A case of severe hypercalcemia with acute renal failure in sarcoidosis: a diagnostic challenge for the emergency department. Eur. J. Emerg. Med. 12 6 (2005) 320-321
55. Waters W.R., Palmer M.V., Nonnecke B.J., Whipple D.L., and Horst R.L. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb. Pathog. 36 1 (2004) 11-17
56. Yang W.C., Chang I.T., and Tsai B.L. Hypercalcemia in renal transplant patients with tuberculosis. Transplant Proc. 32 7 (2000) 1882-1883
57. Yu S., and Cantorna M.T. The vitamin D receptor is required for iNKT cell development. Proc. Natl. Acad. Sci. USA. 105 13 (2008) 5207-5212
58. Zella J.B., McCary L.C., and DeLuca H.F. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch. Biochem. Biophys. 417 1 (2003) 77-80
59. Zhu Y., Mahon B.D., Froicu M., and Cantorna M.T. Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol. 35 1 (2005) 217-224